New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

22

With U.S. hospitals overrun, surgeon general urges Americans to ‘hold on’

U.S. Surgeon General Jerome Adams pleaded with Americans to grasp “the severity of the moment” and remain vigilant against the coronavirus pandemic, as record hospitalizations pushed healthcare professionals to the brink.

26

U.S. posts sharpest weekly rise in Covid-19 deaths since August

The United States recorded the country’s largest weekly rise in Covid-19 deaths since August, increasing 32% from the previous week to average about 1,500 people per day, according to a Reuters analysis of state and county reports.

27

U.S. to begin distributing Regeneron’s Covid-19 antibody therapy

The U.S. government will start distributing Regeneron Pharmaceuticals Inc.’s newly authorized Covid-19 antibody combination on Nov. 24, beginning with more than 30,000 treatment courses, a health official said.

29

Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma

Immunocore’s Phase III IMCgp100-202 trial of tebentafusp compared to investigator’s choice for metastatic uveal melanoma (mUM) met the pre-defined boundaries for statistical significance of the primary endpoint of overall survival in its first pre-planned interim analysis.

30

FDA Action Alert: Blueprint, Liquidia, Revance, Rhythm and Merck

The U.S. Food and Drug Administration’s PDUFA dates for the last week of November 2020 include a review of Liquidia Technologies’ NDA for LIQ861 for the treatment of pulmonary arterial hypertension (PAH).